Skip to content

mbiomics GmbH vs PathAI

mbiomics GmbH logo

mbiomics GmbH

Casting light on the microbiome

44 employees · est. 2020 · Neuried, Germany

VS
PathAI logo

PathAI

Improving patient outcomes with AI-powered pathology

281 employees · est. 2016 · Boston, United States

PathAI is the older company (2020 vs 2016); PathAI is the larger of the two.

Side-by-Side Comparison

mbiomics GmbH PathAI
Founded
2020 2016 older
Headquarters
Neuried, Germany Boston, United States
Employees
44 281 larger
Industry
Biotechnology Biotechnology, Health Care
Funding Stage
Series A Debt Financing
Total Funding
$25.00M $355.20M
Funding Rounds
4 6
Services
Design and development of microbiome-based therapeutics, Fluorescence microscopy-based profiling technology, Microbiome analytics AI-Powered Pathology Solutions, Digital Pathology Platform AISight®, Translational Research Services, Clinical Development Services, Real-World Data Analysis, Companion Diagnostics Development, Biomarker Quantification
Target Customers
Healthcare Providers, Pharmaceutical Companies, Clinical Researchers Biopharma Companies, Academic Medical Centers, Reference Laboratories, Health Systems, Pathology Laboratories
Taxonomy
Microbiome ResearchPrecision MedicineDiagnosticsImmuno-oncologyCompanion DiagnosticsTherapeutic Development +6 AI-Powered PathologyDigital PathologyOncologyImmuno-OncologyNeurodegenerative DiseaseCompanion Diagnostics +8
Website
mbiomics.com pathai.com
mbiomics GmbH logo

About mbiomics GmbH

mbiomics GmbH, headquartered in Germany, is an innovative player in the Biotechnology industry. Established in 2020, the company is driven by the mission of “Casting light on the microbiome,” focusing on revolutionizing understanding of the microbiome to enhance targeted therapies and promote health...

PathAI logo

About PathAI

PathAI, founded in 2016, is carving a niche in the Biotechnology and Health Care sectors by focusing on AI-enhanced pathology. Their slogan, "Improving patient outcomes with AI-powered pathology," encapsulates their mission to leverage machine learning to enhance diagnostic accuracy and treatment ef...

Also comparing in this category

Comparing more than these two?

Get mbiomics GmbH, PathAI and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does mbiomics GmbH compare?

A PDF of mbiomics GmbH and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

mbiomics GmbH was founded in 2020, based in Neuried, Germany, with 44 employees. mbiomics GmbH, headquartered in Germany, is an innovative player in the Biotechnology industry. Established in 2020, the company is driven by the mission of “Casting light on the microbiome,” focusing. PathAI was founded in 2016, based in Boston, United States, with 281 employees. PathAI, founded in 2016, is carving a niche in the Biotechnology and Health Care sectors by focusing on AI-enhanced pathology. Their slogan, "Improving patient outcomes with AI-powered pathology," enc.
mbiomics GmbH has raised $25.00M and PathAI $355.20M. Latest stage: mbiomics GmbH Series A, PathAI Debt Financing.
Both work in Biotechnology and list precision medicine, immuno-oncology and companion diagnostics among their focus areas.

Compare mbiomics GmbH with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at mbiomics GmbH on 28 May 2026, and PathAI on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout